Barbara B. Hill's most recent trade in Omega Healthcare Investors, Inc. was a trade of 7,079 OP Units done . Disclosure was reported to the exchange on June 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 7,079 | 49,073 | - | - | OP Units | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 7,079 | 0 | - | - | Profits Interest Units | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 6,102 | 6,102 | - | - | Profits Interest Units | |
| Integra Lifesciences Holdings Corp | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 17,700 | 151,191 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 6,638 | 133,491 (0%) | 0% | 0 | Common Stock | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2025 | 7,472 | 0 | - | - | Profits Interest Units | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2025 | 7,472 | 41,994 | - | - | OP Units | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 7,079 | 7,079 | - | - | Profits Interest Units | |
| Integra Lifesciences Holdings Corp | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 19,592 | 126,853 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 6,939 | 107,261 (0%) | 0% | 0 | Common Stock | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 8,087 | 28,122 | - | - | OP Units | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 8,087 | 13,872 | - | - | Profits Interest Units | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 7,472 | 21,959 | - | - | Profits Interest Units | |
| Integra Lifesciences Holdings Corp | Barbara B. Hill | Director | Purchase of securities on an exchange or from another person at price $ 27.40 per share. | 21 May 2024 | 36,350 | 36,350 (0%) | 0% | 27.4 | 995,816 | Common Stock |
| Integra Lifesciences Holdings Corp | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 8,696 | 100,322 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 3,163 | 91,626 (0%) | 0% | 0 | Common Stock | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2023 | 8,304 | 20,035 | - | - | OP Units | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2023 | 8,304 | 14,487 | - | - | Profits Interest Units | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 8,087 | 22,791 | - | - | Profits Interest Units | |
| Integra Lifesciences Holdings Corp | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 4,486 | 88,463 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 1,631 | 83,977 (0%) | 0% | 0 | Common Stock | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 8,304 | 14,704 | - | - | Profits Interest Units | |
| Integra Lifesciences Holdings Corp | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 3,456 | 82,346 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 1,265 | 78,890 (0%) | 0% | 0 | Common Stock |